Dilsaver Evelyn S 4

What Happened

• Evelyn S. Dilsaver, a director of HealthEquity, Inc. (HQY), was granted 2,877 restricted stock units (RSUs) on June 25, 2026. The reported acquisition price is $0.00, so there was no cash paid at grant and the immediate reported value is $0.
• The filing classifies the transaction as an award/grant (code A). The RSUs convert to one share of common stock per unit upon vesting.

Key Details

• Transaction date: 2026-06-25; Filing date: 2026-06-29.
• Grant size and price: 2,877 RSUs @ $0.00 (total reported cost $0).
• Shares owned after transaction: Not specified in the provided Form 4 details.
• Footnote F1: Each RSU equals a contingent right to one share. The RSUs vest in full on the earlier of (i) June 25, 2027, or (ii) the issuer’s next annual stockholder meeting in June 2027; vested shares will be delivered to the reporting person upon vesting.
• Footnote F2 and the remarks: F2 states an option is immediately exercisable but does not apply to this RSU grant; a Power of Attorney reference was included (previously filed June 26, 2023).
• No late-filing flag (transactionTimeliness = 'L') was provided in the information you supplied.

Context

• RSU grants are a common form of director compensation and represent a future right to company stock rather than an immediate purchase. They typically do not signal an immediate change in insider sentiment and only become shares (and usually taxable) upon vesting or delivery.
• This transaction was a grant (not a sale or purchase). For retail investors, grants are routine but worth tracking for potential dilution and future insider holdings once vested.